|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn961570554 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
160326s2012 nyu ob 001 0 eng d |
040 |
|
|
|a AZK
|b eng
|e rda
|e pn
|c AZK
|d OCLCO
|d YDXCP
|d N$T
|d E7B
|d OCLCF
|d EBLCP
|d LOA
|d MERUC
|d COCUF
|d AGLDB
|d ICA
|d MOR
|d PIFPO
|d OCLCQ
|d ZCU
|d OCL
|d U3W
|d D6H
|d STF
|d WRM
|d VTS
|d NRAMU
|d ICG
|d INT
|d VT2
|d OCLCQ
|d WYU
|d TKN
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d M8D
|d OCLCQ
|d K6U
|d OCLCQ
|d AJS
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 828140624
|a 923653492
|a 962708945
|a 1065824193
|
020 |
|
|
|a 1619423510
|
020 |
|
|
|a 9781619423510
|
020 |
|
|
|z 9781619423466
|q (hardcover)
|
020 |
|
|
|z 9781619423510
|
020 |
|
|
|z 1619423464
|
029 |
1 |
|
|a AU@
|b 000051707081
|
029 |
1 |
|
|a DEBBG
|b BV041049669
|
029 |
1 |
|
|a DEBBG
|b BV043961303
|
029 |
1 |
|
|a DEBBG
|b BV044087196
|
029 |
1 |
|
|a DEBSZ
|b 481298940
|
029 |
1 |
|
|a NZ1
|b 15492303
|
035 |
|
|
|a (OCoLC)961570554
|z (OCoLC)828140624
|z (OCoLC)923653492
|z (OCoLC)962708945
|z (OCoLC)1065824193
|
050 |
|
4 |
|a QR188.8
|
072 |
|
7 |
|a MED
|x 085030
|2 bisacsh
|
082 |
0 |
4 |
|a 617.9/5
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Acute rejection :
|b risk factors, management and complications /
|c Takumi Kobayashi, Riku Arai, editors.
|
264 |
|
1 |
|a Hauppauge, NY :
|b Nova Science Publishers, Incorporated,
|c 2012.
|
300 |
|
|
|a 1 online resource (xi, 197 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Immunology and immune system disorders
|
490 |
1 |
|
|a Surgery--procedures, complications, and results
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS -- ACUTE REJECTION: RISK FACTORS, MANAGEMENT AND COMPLICATIONS -- Library of Congress Cataloging-in-Publication Data -- Contents -- Preface -- Chapter 1: HLA and Non-HLA Genes Polymorphisms: Susceptibility and Severity in Tunisian Patients with Rheumatoid Arthritis -- Abstract -- 1. Introduction -- 2. Evaluation of Genetic Predisposition to RA -- 2.1. Prevalence of RA -- 2.2. Familial Clustering Studies -- 2.3. Twins Studies -- 3. Identification of Candidate Genes -- 3.1. Linkage Studies
|
505 |
8 |
|
|a 3.2. Candidate Gene Association Studies4. Results of Linkage Studies in RA -- 5. HLA Association With RA -- 6. Non HLA Candidate Genes Case-control Studies -- 6.1. Protein Tyrosine Phosphatase Non-Receptor, Type 22 (PTPN22) -- 6.2. Tumor Necrosis Factor Receptor Type 2 (TNF-R2) -- 6.3. Peptidyl Arginine Deiminase 4 (PADI 4) -- 6.4. Fc γ Receptor IIIa (FcγRIIIa) -- 6.5. Interleukin 1 Receptor Antagonist (IL-1Ra) -- 6.6. Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) -- 6.7. Apo-1/Fas (CD95) -- 6.8. Adhesion Molecules -- 7. Patients and Methods
|
505 |
8 |
|
|a 7.1. Patients and Controls7.2. Methods -- 7.3. Statistical Methods -- 8. Results -- 8.1. HLA Typing -- a/ DRB1 Genotyping -- b/ DRB1*04 Sub-typing -- 8.2. PTPN22 Genotyping -- 8.3. CTLA-4 Genotyping -- 8.4. Apo-1/Fas Genotyping -- 8.5. FcγR Genotyping -- 8.6. Adhesion Molecules Genotyping -- 8.7. IL1 Family Polymorphisms Genotyping -- a/ IL1α (C/T -889) -- b/ IL1Ra (Intron 2) -- c/ IL1β C/T -511 and C/T +3954 -- 9. Discussion -- Conclusion -- Acknowledgment -- References
|
505 |
8 |
|
|a Chapter 2: Mechanisms, Management and Consequences of Acute Cellular and Antibody Mediated Rejection in Solid Organ and Reconstructive TransplantationAbstract -- 1. Acute Rejection -- 2. Kidney Transplantation -- 2.1 The Banff Classification -- 2.2 Acute Antibody-Mediated Rejection in Kidney Transplantation -- 2.3 Acute T-Cell-Mediated Rejection in Kidney Transplantation -- 2.3.1. Steps in TCMR � 3 Signals [12] -- 3. Pancreas Transplantation -- 3.1 The Banff Classification -- 3.2 Acute Antibody-Mediated Rejection in Pancreas Transplantation
|
505 |
8 |
|
|a 3.3 Acute T-Cell-Mediated Rejection in Pancreas Transplantation4. Liver Transplantation -- 4.1 Banff Schema for Grading of Liver Allograft Rejection -- 4.2 Acute Antibody-Mediated Rejection in Liver Transplantation -- 4.3 Acute T-Cell-Mediated Rejection in Liver Transplantation -- 5. Intestinal and Multivisceral Transplantation -- 5.2 Acute Antibody-Mediated Rejection in Intestinal Transplantation -- 5.3 Acute T-Cell-Mediated Rejection in Intestinal Transplantation -- 6. Vascularized Composite Allotransplantation
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Graft rejection.
|
650 |
|
0 |
|a Transplantation immunology.
|
650 |
|
6 |
|a Rejet (Biologie)
|
650 |
|
6 |
|a Greffe (Chirurgie)
|x Immunologie.
|
650 |
|
7 |
|a MEDICAL
|x Surgery
|x Plastic & Cosmetic.
|2 bisacsh
|
650 |
|
7 |
|a Graft rejection.
|2 fast
|0 (OCoLC)fst00945860
|
650 |
|
7 |
|a Transplantation immunology.
|2 fast
|0 (OCoLC)fst01154917
|
776 |
0 |
8 |
|i Print version:
|z 9781619423466
|z 1619423464
|
830 |
|
0 |
|a Immunology and immune system disorders.
|
830 |
|
0 |
|a Surgery--procedures, complications, and results series.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540916
|z Texto completo
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3017734
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10654705
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 540916
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7252251
|
994 |
|
|
|a 92
|b IZTAP
|